880
Participants
Start Date
July 31, 2012
Primary Completion Date
June 30, 2014
Study Completion Date
September 30, 2014
Pegylated interferon lambda (pegIFNλ)
Syringe, Subcutaneous, 180 μg, Once weekly, 24 weeks
Pegylated interferon lambda (pegIFNλ)
Syringe, Subcutaneous, 180 μg, Once weekly, 12 weeks
Pegylated interferon alfa-2a (pegIFNα-2a)
Syringe, Subcutaneous, 180 μg, Once weekly, 24 weeks
Ribavirin
Tablets, Oral, 400 mg, Twice daily, 24 weeks
Ribavirin
Tablets, Oral, 400 mg, Twice daily, 12 weeks
Daclatasvir
Tablets, Oral, 60 mg, Once daily, 12 weeks
Placebo matching Daclatasvir
Tablets, Oral, 0 mg, Once daily, 12 weeks
Local Institution, Taichung
Local Institution, Tainan City
Local Institution, Kaohsiung City
Local Institution, Brussels
Local Institution, Prov de Santa Fe
Local Institution, Darlinghurst
Local Institution, Randwick
Local Institution, Camperdown
Local Institution, Concord
Local Institution, Westmead Nsw
Local Institution, Leuven
Local Institution, Melbourne
Local Institution, Parville
Local Institution, Clayton Vic
Local Institution, Liège
Local Institution, Herston
Local Institution, Brisbane
Local Institution, Greenslopes
Local Institution, Córdoba
Local Institution, Adelaide
Local Institution, Fremantle
Local Institution, Mar del Plata
Local Institution, Tlalpan
University Of Pittsburgh Medical Center, Ctr For Liver Diseases, Pittsburgh
Local Institution, Milan
Local Institution, Milan
Local Institution, Novara
Carolinas Medical Center, Charlotte
Gastrointestinal Specialists Of Georgia, Marietta
Orlando Immunology Center, Orlando
Orlando Infectious Disease Center, Orlando
Local Institution, Montpellier
Local Institution, Guadalajara
Local Institution, Guadalajara
Consultants For Clinical Research, Cincinnati
Henry Ford Hospital, Detroit
Local Institution, Florence
Local Institution, Thessaloniki
Local Institution, Yunlin
Healthcare Research Consultants, Tulsa
Texas Clinical Research Institute, Llc, Arlington
St. Luke'S Episcopal Hospital - Baylor College Of Medicine, Houston
Local Institution, Napoli
Local Institution, Kaohsiung City
Clinical Research Centers Of America, Murray
Mayo Clinic Arizona, Phoenix
Local Institution, Auckland
Precision Research Institute, Llc, San Diego
Local Institution, Clichy
Medical Associates Research Group, San Diego
Local Institution, Créteil
University Of California, San Francisco/Sf General Hospital, San Francisco
Kaiser Permanente Medical Center, San Francisco
The Queen'S Liver Center, Honolulu
Local Institution, Moscow
Local Institution, Moscow
Local Institution, Singapore
Local Institution, Moscow
Local Institution, Moscow
Local Institution, Singapore
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Smolensk
Local Institution, Samara
Local Institution, Chelyabinsk
Local Institution, Singapore
Local Institution, Krasnoyarsk
Local Institution, Irkutsk
Local Institution, Minato-ku
Local Institution, Bunkyo-ku
Local Institution, Musashino-shi
Local Institution, Kawasaki-shi
Local Institution, Saitama
Local Institution, Iruma-gun
Local Institution, Wakayama
Local Institution, Kobe
Local Institution, Okayama
Local Institution, Hiroshima
Local Institution, Takamatsu
Local Institution, Kitakyushu
Local Institution, Fukuoka
Local Institution, Fukuoka
Local Institution, Saga
Local Institution, Miyazaki
Local Institution, Kagoshima
Yale University School Of Medicine, New Haven
Local Institution, Autonoma
Local Institution, Buenos Aires
Local Institution, Ciudad de Buenos Aires
Local Institution, Ciudad de Buenos Aires
Local Institution, Quilmes
Local Institution, Fitzroy
Local Institution, Santiago
Local Institution, Hong Kong
Local Institution, Tai Po
Local Institution, Guadalajara
Local Institution, Hus
Local Institution, Nice
Local Institution, Athens
Local Institution, Sapporo
Local Institution, Tsuchiura-shi
Local Institution, Distrito Federal
Local Institution, Mexico City
Local Institution, Mexico City
Local Institution, Mexico City
Local Institution, Amsterdam
Local Institution, Leiden
Local Institution, Busan
Local Institution, Busan
Local Institution, Daegu
Local Institution, Daegu
Local Institution, Gyeonggi-do
Local Institution, Gyeonggi-do
Local Institution, Gyeongsangnam-do
Local Institution, Incheon
Local Institution, Incheon
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Hull
Local Institution, Nottingham
Local Institution, Birmingham
Local Institution, London
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY